Fortrea is an independent, publicly traded contract research organization (CRO) that supports pharmaceutical, biotech, medical device, and diagnostic clients with comprehensive clinical trial management, clinical pharmacology, and patient access services. Boasting over 30 years of legacy from predecessors like Covance and Labcorp’s drug development arm, Fortrea handles all phases of clinical research globally, with expertise across therapeutic areas including oncology, neuroscience, and vaccines.